Provider
VMAT2 Inhibitors (Vesicular Monoamine Transporter 2) - Medicaid - Effective Date 03/01/2025
Program effective Date: Mar 01, 2025
Documents & Forms Results
Displaying 201 - 210 of 3102 results
Provider
VMAT2 Inhibitors (Vesicular Monoamine Transporter 2) - Commercial - Effective Date 03/01/2025
Program effective Date: Mar 01, 2025
Provider
Amifampridine (Firdapse) - Medicaid - Effective Date 03/01/2025
Program effective Date: Mar 01, 2025
Provider
Amifampridine (Firdapse) - Commercial - Effective Date 03/01/2025
Program effective Date: Mar 01, 2025
Provider
Inhaled Antibiotics Duplicate Therapy - Commercial - Effective Date 03/01/2025
Program effective Date: Mar 01, 2025
Provider
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) - Medicaid - Effective Date 03/01/2025
Program effective Date: Mar 01, 2025
Provider
ATTR Amyloidosis - Medicaid - Effective 03/01/2025
Program effective Date: Mar 01, 2025
Provider
ATTR Amyloidosis - Commercial - Effective Date 03/01/2025
Program effective Date: Mar 01, 2025
Provider
Hypoactive Sexual Desire Disorder (HSDD) - Commercial - Effective Date 03/01/2025
Program effective Date: Mar 01, 2025
Provider
Hyperhidrosis - Commercial - Effective Date 03/01/2025
Program effective Date: Mar 01, 2025